Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma
Gaynor, E. R., Weiss, G. R., Margolin, K. A., Aronson, F. R., Sznol, M., Demchak, P., Grima, K. M., Fisher, R. I., Boldt, D. H., Doroshow, J. H., Bar, M. H., Hawkins, M. J., Mier, J. W., Caliendo, G.Volume:
82
Language:
english
Journal:
JNCI Journal of the National Cancer Institute
DOI:
10.1093/jnci/82.17.1397
Date:
September, 1990
File:
PDF, 557 KB
english, 1990